Topics

Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections

20:13 EDT 26 Mar 2020 | Xconomy

Forge Therapeutics has set an agreement with Roche that gives the Swiss pharma giant the option to license a new antibiotic Forge is developing to treat serious drug-resistant bacterial lung infections. This week the preclinical-stage San Diego-based biotech announced that under the deal Forge will retain control of the program, FG-LpxC LUNG, until Roche decides […]

Original Article: Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections

NEXT ARTICLE

More From BioPortfolio on "Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...